Add to ORKGWe report 2 cases illustrating that it is too simplistic to link nevirapine (NVP) toxicity exclusively to individuals with immune preservation. Not enough is known about the mechanism of hepatotoxicity or cutaneous eruption to predict these events. This type of hypersensitivity reaction occurs rarely among HIV-exposed infants taking NVP prophylaxis or antiretroviral therapy(ART)-experienced adults with complete plasma viral load suppression. Conversely, HIV-uninfected adults and ART-naive pregnant women appear to be disproportionately affected by the adverse effects of NVP
BACKGROUND: A single dose of nevirapine during labor reduces perinatal transmission of human immunod...
Objective: The relationships between adverse events (AEs) and plasma concentrations of nevirapine (N...
Intrapartum and neonatal single-dose nevirapine (NVP) reduces the risk of mother-to-child HIV transm...
Predictors of adverse events (AE) associated with nevirapine use are needed to better understand rep...
The new way with nevirapine was reported to prevent mother-to-child transmission of the AIDS virus (...
Nevirapine was the first non-nucleoside drug (NNRTI) to be approved by the Federal Drug Administrati...
The majority of antiretroviral treatment programmes in sub-Saharan Africa are scaling up antiretrovi...
Objective: The general objective of the study was to determine incidence of nevirapine toxicity in p...
The majority of antiretroviral treatment programmes in sub-Saharan Africa are scaling up antiretrovi...
Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI) is one of the important compone...
The risk of adverse drug events associated with nevirapine (NVP) is suggested to be greater in pregn...
International audienceBACKGROUND: In resource-limited settings where nevirapine-containing regimen i...
Background: Hepatotoxicity is one of the most serious complications of highly active antiretroviral ...
Nevirapine (viramune) is a nonnucleoside reverse transcriptase inhibitor commonly used in combinatio...
Exposure to single dose nevirapine during labor (SD-NVP) to prevent mother to child transmission of ...
BACKGROUND: A single dose of nevirapine during labor reduces perinatal transmission of human immunod...
Objective: The relationships between adverse events (AEs) and plasma concentrations of nevirapine (N...
Intrapartum and neonatal single-dose nevirapine (NVP) reduces the risk of mother-to-child HIV transm...
Predictors of adverse events (AE) associated with nevirapine use are needed to better understand rep...
The new way with nevirapine was reported to prevent mother-to-child transmission of the AIDS virus (...
Nevirapine was the first non-nucleoside drug (NNRTI) to be approved by the Federal Drug Administrati...
The majority of antiretroviral treatment programmes in sub-Saharan Africa are scaling up antiretrovi...
Objective: The general objective of the study was to determine incidence of nevirapine toxicity in p...
The majority of antiretroviral treatment programmes in sub-Saharan Africa are scaling up antiretrovi...
Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI) is one of the important compone...
The risk of adverse drug events associated with nevirapine (NVP) is suggested to be greater in pregn...
International audienceBACKGROUND: In resource-limited settings where nevirapine-containing regimen i...
Background: Hepatotoxicity is one of the most serious complications of highly active antiretroviral ...
Nevirapine (viramune) is a nonnucleoside reverse transcriptase inhibitor commonly used in combinatio...
Exposure to single dose nevirapine during labor (SD-NVP) to prevent mother to child transmission of ...
BACKGROUND: A single dose of nevirapine during labor reduces perinatal transmission of human immunod...
Objective: The relationships between adverse events (AEs) and plasma concentrations of nevirapine (N...
Intrapartum and neonatal single-dose nevirapine (NVP) reduces the risk of mother-to-child HIV transm...